In addition, a prior case report presented in abstract form at the 2018 American Epilepsy society meeting7 described an individual with a different KCNMA1 variant (N536H, also a GOF mutation) whose PNKDs were successfully treated with dextroamphetamine.8 Here, KCNMA1 is linked to epilepsy.